相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Raffael Nachbagauer et al.
NATURE MEDICINE (2021)
Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin
Bo Ryoung Park et al.
SCIENTIFIC REPORTS (2021)
A Strategy to Elicit M2e-Specific Antibodies Using a Recombinant H7N9 Live Attenuated Influenza Vaccine Expressing Multiple M2e Tandem Repeats
Daria Mezhenskaya et al.
BIOMEDICINES (2021)
Effectiveness of repeated influenza vaccination among the elderly population with high annual vaccine uptake rates during the three consecutive A/H3N2 epidemics
Joon Young Song et al.
VACCINE (2020)
Immunagenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
David I. Bernstein et al.
LANCET INFECTIOUS DISEASES (2020)
Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes
Hsin-Yu Liao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope
Ki-Hye Kim et al.
VIROLOGY (2020)
Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals
Carole Henry et al.
CELL HOST & MICROBE (2019)
The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines
Xavier Saelens
JOURNAL OF INFECTIOUS DISEASES (2019)
Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay
Wonil Chae et al.
VACCINE (2019)
Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans
Surender Khurana et al.
NATURE COMMUNICATIONS (2019)
Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model
Wen-Chun Liu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets
Nedzad Music et al.
NPJ VACCINES (2019)
Immunosenescence and human vaccine immune responses
Stephen N. Crooke et al.
IMMUNITY & AGEING (2019)
Diminished B-Cell Response After Repeat Influenza Vaccination
Mrinmoy Sanyal et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Is It Possible to Develop a Universal Influenza Virus Vaccine? Potential Target Antigens and Critical Aspects for a Universal Influenza Vaccine
Florian Krammer et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study
Itziar Casado et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2018)
Advances in measuring influenza burden of disease
Vernon J. Lee et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2018)
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
A. Danielle Iuliano et al.
LANCET (2018)
Mouse strain and sex as determinants of immune response to trivalent influenza vaccine
Raisa Petrovic et al.
LIFE SCIENCES (2018)
Change in the efficacy of influenza vaccination after repeated inoculation under antigenic mismatch: A systematic review and meta-analysis
Nobuhisa Morimoto et al.
VACCINE (2018)
Repeated annual influenza vaccination and vaccine effectiveness: review of evidence
Edward A. Belongia et al.
EXPERT REVIEW OF VACCINES (2017)
Characterization of FcγRIIIA effector cells used in in vitro ADCC bioassay: Comparison of primary NK cells with engineered NK-92 and Jurkat T cells
Yao-Te Hsieh et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers
Vivian K. Y. Leung et al.
VACCINE (2017)
Immunogenicity and efficacy of replication-competent recombinant influenza virus carrying multimeric M2 extracellular domains in a chimeric hemagglutinin conjugate
Min-Chul Kim et al.
ANTIVIRAL RESEARCH (2017)
Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection
David J. DiLillo et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin
Yu-Na Lee et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11
Mark G. Thompson et al.
VACCINE (2016)
Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans
Raffael Nachbagauer et al.
MBIO (2016)
Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease
Yu-Na Lee et al.
VIROLOGY (2015)
Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons
Huong Q. McLean et al.
CLINICAL INFECTIOUS DISEASES (2014)
Supplementation of Influenza Split Vaccines with Conserved M2 Ectodomains Overcomes Strain Specificity and Provides Long-term Cross Protection
Min-Chul Kim et al.
MOLECULAR THERAPY (2014)
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo
David J. DiLillo et al.
NATURE MEDICINE (2014)
Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection
Min-Chul Kim et al.
ANTIVIRAL RESEARCH (2013)
Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
Florian Krammer et al.
JOURNAL OF VIROLOGY (2013)
Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus
Min-Chul Kim et al.
MOLECULAR THERAPY (2013)
New World Bats Harbor Diverse Influenza A Viruses
Suxiang Tong et al.
PLOS PATHOGENS (2013)
Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes
Rong Hai et al.
JOURNAL OF VIROLOGY (2012)
Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection
Karim El Bakkouri et al.
JOURNAL OF IMMUNOLOGY (2011)
Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus
Jae-Min Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Induction of heterosubtypic immunity to influenza virus by intranasal immunization
Fu-Shi Quan et al.
JOURNAL OF VIROLOGY (2008)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
分享论文
